EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

miR-24-3p Is Antiviral Against SARS-CoV-2 by Downregulating Critical Host Entry Factors

Parrish Evers iD, Spencer M Uguccioni, Nadine Ahmed, Magen E Francis iD, Alyson A Kelvin, John P Pezacki iD

Viruses · 2024

DOI: 10.3390/v16121844 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Parrish Evers und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa, ON K1N 6N6, Canada. Hauptthemen laut MEDLINE: MicroRNAs, SARS-CoV-2, Virus Internalization, COVID-19. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes for Health Research (CIHR), Natural Sciences and Engineering Council of Canada (NSERC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite all the progress in treating SARS-CoV-2, escape mutants to current therapies remain a constant concern. Promising alternative treatments for current and future coronaviruses are those that limit escape mutants by inhibiting multiple pathogenic targets, analogous to the current strategies for treating HCV and HIV. With increasing popularity and ease of manufacturing of RNA technologies for vaccines and drugs, therapeutic microRNAs represent a promising option. In the present work, miR-24-3p was identified to inhibit SARS-CoV-2 entry, replication, and production; furthermore, this inhibition was retained against common mutations improving SARS-CoV-2 fitness. To determine the mechanism of action, bioinformatic tools were employed, identifying numerous potential effectors promoting infection targeted by miR-24-3p. Of these targets, several key host proteins for priming and facilitating SARS-CoV-2 entry were identified: furin, NRP1, NRP2, and SREBP2. With further experimental analysis, we show that miR-24-3p directly downregulates these viral entry factors to impede infection when producing virions and when infecting the target cell. Furthermore, we compare the findings with coronavirus, HCoV-229E, which relies on different factors strengthening the miR-24-3p mechanism. Taken together, the following work suggests that miR-24-3p could be an avenue to treat current coronaviruses and those likely to emerge.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsSARS-CoV-2Virus InternalizationCOVID-19Virus ReplicationHumansDown-RegulationFurinAntiviral AgentsAnimalsChlorocebus aethiopsVero CellsHost-Pathogen InteractionsHEK293 Cells

Stichwörter der Autor:innen

COVID-19HCoV-229ENRP1NRP2SARS-CoV-2SREBP2furinmiR-24miR-24-3pmicroRNA

Substanzen

MicroRNAsMIRN24 microRNA, humanFurinAntiviral AgentsFURIN protein, human

Autor:innen und Institutionen

  • Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa, ON K1N 6N6, Canada.
  • Vaccine and Infectious Disease Organization (VIDO), University of Saskatchewan, Saskatoon, SK S7N 5E3, Canada.
  • Department of Biochemistry, Microbiology, and Immunology, University of Saskatchewan, Saskatoon, SK S7N 5E3, Canada.

ORCID-Profile: Parrish Evers, Magen E Francis, John P Pezacki

Förderung

  • Canadian Institutes for Health Research (CIHR)
  • Natural Sciences and Engineering Council of Canada (NSERC)

Zitieren

APA

Evers, P., Uguccioni, S. M., Ahmed, N., Francis, M. E., Kelvin, A. A., & Pezacki, J. P. (2024). miR-24-3p Is Antiviral Against SARS-CoV-2 by Downregulating Critical Host Entry Factors. Viruses. https://doi.org/10.3390/v16121844

Vancouver

Evers P, Uguccioni SM, Ahmed N, Francis ME, Kelvin AA, Pezacki JP. miR-24-3p Is Antiviral Against SARS-CoV-2 by Downregulating Critical Host Entry Factors. Viruses. 2024. doi:10.3390/v16121844

BibTeX
@article{Evers2024,
  author = {Evers, Parrish and Uguccioni, Spencer M and Ahmed, Nadine and Francis, Magen E and Kelvin, Alyson A and Pezacki, John P},
  title = {miR-24-3p Is Antiviral Against SARS-CoV-2 by Downregulating Critical Host Entry Factors},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16121844}
}
Kostenlos starten →